Release Date: 25/08/10 08:26 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 116.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%